Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $3.86 Million - $4.52 Million
120,400 Added 62.29%
313,700 $10.4 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $6.9 Million - $7.98 Million
-190,900 Reduced 49.69%
193,300 $7.09 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $14.8 Million - $19.3 Million
375,700 Added 4420.0%
384,200 $15.7 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $4.95 Million - $6.46 Million
-118,600 Reduced 93.31%
8,500 $435,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $5.56 Million - $6.79 Million
127,100 New
127,100 $5.56 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $4.5 Million - $5.33 Million
-96,700 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $7.25 Million - $8.99 Million
-158,500 Reduced 62.11%
96,700 $5.01 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $5.46 Million - $6.16 Million
163,000 Added 176.79%
255,200 $9.25 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $4.28 Million - $4.86 Million
-130,000 Reduced 58.51%
92,200 $3.61 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $2.21 Million - $2.86 Million
-67,900 Reduced 23.41%
222,200 $7.98 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $5.23 Million - $6.34 Million
151,600 Added 109.46%
290,100 $12.8 Million
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $2.84 Million - $3.02 Million
86,000 Added 163.81%
138,500 $5.03 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $3.37 Million - $3.91 Million
-105,700 Reduced 66.81%
52,500 $1.86 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $2.93 Million - $3.11 Million
88,200 Added 126.0%
158,200 $5.73 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $2.17 Million - $2.39 Million
70,000
70,000 $2.5 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.